Peptide purity thresholds — 95%, 98%, 99% and what each is good for
What HPLC area-percent purity levels actually mean for downstream applications, why "higher is better" is not always true, and the cost trade-offs.
Peptide purity is reported as HPLC area percent and clusters at 95%, 98% and 99%. 95% is a reagent baseline, 98% is the standard for published in-vitro work, and 99% suits reference and quantitative work. Higher purity costs more and is not always better; claims above 99% deserve scepticism.
By the Bench Grade Research Team ·
Peptide purity levels are usually reported as HPLC area percentages and clustered around three thresholds: 95%, 98%, and 99%. Each threshold has a different cost-to-produce profile and different downstream-application implications. Understanding what each level is actually good for — and where the diminishing returns set in — helps you specify the right grade for your work without paying for over-spec.
95% purity — research-grade reagent baseline
95% HPLC area is the practical floor for most research-context work. Below this level, the impurity peaks start to interfere with downstream measurements: in binding assays, the 5%+ impurities may have their own binding profiles; in cell culture, impurities may have their own cytotoxic effects; in structural studies, NMR or crystallography results can be confounded by the impurity profile.
95% purity is appropriate for: bulk screening assays where you have orthogonal confirmation of activity, preliminary in-vitro work where you are choosing between candidates rather than characterizing one, and reagent uses where the peptide is consumed (e.g. as a substrate for an enzyme).
98% purity — standard for published in-vitro work
98% HPLC area is the level at which most published in-vitro protocols specify their peptide reagents. The impurity profile is low enough that binding-affinity measurements, kinetics studies, and pharmacology characterizations are not materially affected by side products. The cost to produce 98% vs 95% material is roughly 1.3–1.6× because of the additional purification cycles required.
98% purity is appropriate for: most peer-reviewed in-vitro pharmacology work, structural studies under standard conditions, reference standards for analytical method development, and binding affinity / kinetics work that will be published.
99% purity — high-confidence reference work
99% HPLC area is the level used for reference standards and for assays where the precision requirements exceed what 98% material can support. The cost to produce 99% vs 98% material is again roughly 1.3–1.5× because the final 1% of impurity removal requires either an additional purification step or a higher-resolution column that processes less material per run.
99% purity is appropriate for: reference standards used to calibrate other measurements, structural NMR where minor impurities would contaminate the spectrum, isothermal titration calorimetry where small thermodynamic contributions from impurities matter, and any work where the peptide concentration must be known to ±1% precision.
Why higher is not always better
Above 99% HPLC area, the cost-to-produce climbs sharply (often 2–3× per percentage point) but the downstream-application benefit plateaus. Going from 99% to 99.5% material is technically feasible but rarely justifiable outside of regulatory-submission contexts. For research-context work, the right question is rarely "what's the maximum purity available" but "what's the minimum purity that supports the measurement I need to make."
The 99.9% red flag
Bench Grade's purity standard
The Bench Grade catalog ships at ≥98% HPLC area as the minimum acceptable specification, with most lots running 99.0–99.5% as a typical range. The COA reports the actual area % observed for each specific lot — not a generic "≥99%" spec line, but the integrated number from that lot's chromatogram. If a particular research workflow requires ≥99% material specifically, we can pre-screen lots before shipping; contact us for the workflow.
References
Primary literature for the compounds discussed above. Links open the record on PubMed.
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing Sikiric P, et al. Curr Pharm Des. 2018. PMID 29998800 → · summary
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration Chang CH, et al. J Appl Physiol. 2011. PMID 21030672 → · summary
- The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity Kim SJ, et al. Physiol Rep. 2019. PMID 31293078 → · summary
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance Lee C, et al. Cell Metab. 2015. PMID 25738459 → · summary
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance Lee C, et al. Cell Metab. 2015. PMID 25738459 → · summary
- Thymosin beta 4 improves dermal burn wound healing via downregulation of receptor of advanced glycation end products in db/db mice Xu TJ, et al. Biochim Biophys Acta. 2014. PMID 25230158 → · summary
- Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat Cerovecki T, et al. J Orthop Res. 2010. PMID 20225319 → · summary
- Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat Novinscak T, et al. Surg Today. 2008. PMID 18668315 → · summary
Primary sources
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingCurr Pharm Des · 2018
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migrationJ Appl Physiol · 2011
- The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivityPhysiol Rep · 2019 · animal study
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin ResistanceCell Metab · 2015 · animal study
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin ResistanceCell Metab · 2015 · animal study
- Thymosin beta 4 improves dermal burn wound healing via downregulation of receptor of advanced glycation end products in db/db miceBiochim Biophys Acta · 2014 · animal study
Frequently asked questions
- Is 99% peptide purity always better than 98%?
- No. Higher purity costs more and the additional purification can reduce yield. For most in-vitro work 98% is the established standard, and the money is better spent on independent verification than on the last percentage point.
- What does HPLC area percent actually measure?
- The proportion of total UV absorbance under the main peak relative to all peaks in the run. It is a relative measure of the material that elutes and is detected — it is not a measure of how much peptide is in the vial.
- Why is a claim of 99.9% purity a red flag?
- Because it exceeds what routine solid-phase synthesis and purification reliably deliver, and because area-percent measurement at that level is at the limits of the method. The claim usually indicates a number that was not measured.
Compounds discussed in this guide
More on quality control
- How to read a peptide Certificate of Analysishow to read a Certificate of AnalysisThe five numbers that actually matter on a peptide COA, what they mean, and the red flags that should make you choose a different supplier.
- HPLC vs mass spec vs amino acid analysis — what each test provesA practical guide to the three peptide QC methods, what each can prove and disprove, and why a complete QC profile requires all three.
- Cloudy, clumped or undissolved — diagnosing a failed reconstitutionFour appearances, four different causes. What a hazy vial, a gel, floating strands or a stubborn cake each tell you about the material and the technique.
All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.




